Member Info for Henley2

Dodgy broker TPI probably up to their usual tricks…JMHO

He’s too busy talking up the Immupharma story.

Meanwhile, he can’t tell shareholders the identity of the entity challenging our product.

Well done ec keep up the good work!

Edzi, or should I call you Del Boy?

I think you’re slightly annoyed with me for pointing out the delays.

Reading your previous postings on the company it seems you were in for a short term trade but things have changed.

Oh dear touched a raw nerve have I edzi.

I believe the drill cores have been sent to Joburg.

Maybe the company shouldn’t give timelines and just say we’ll get results when we get them.

rome wasn’t built in a day, however if this bunch were undertaking the task it would probably take 500 years! **** poor expectations management on the timing of the release of the assay results. i find it hard to believe they will be releasing any sort of resource estimate in the 1h25.

meanwhile the share price stays marooned at not much more than 0.3p. well done chaps keep up the good work. seems they have no influence or leverage over the company performing the assay tests on the drill core.

Has this been tipped somewhere?

Is there any substance behind the recent share price gain?

Thoughts anyone?

Turner Pope says it all.

Need a change in broker if this company is to be taken seriously.

Great point.

Are we up against a multinational with huge resources or a one man band?

If the former we are toast, but the CEO seems to think that treating shareholders like mushrooms is the way forward!

Patience of a saint required here.

The contrast with OMI in terms of time to turnaround assay results is startling, 4/5 days versus weeks/months! Hard to believe they will have a resource estimate by end of January.

Another Sunday Roast special!

Now we know the real reason for the delayed launch.

What a disaster!

Too many traders in AIM market.

Not sure whether a strategic investor would be good or bad news.

Premium placing good but may cap eventual upside of a buyout.

The only clarity Incanthera management have on the launch date is that they haven’t got a Scooby on when/if ever it’s going to take place!

Company has no control whatsoever on where it is heading.

says it all when the non-executive chairman has to give the bad news, whilst the ceo can’t be ****d to say a thing. only good news is that his 51 million shares have lost £250k in value and might concentrate his mind on creating some value out of this mess.

economic with the truth is how i would describe the ceo, e.g. when the jorc was issued there was no mention of triggering the performance share award!

is our ceo just another aussie spouting bull**** and dreams?

the verkhuba asset will now not be sold, presumably because offers weren’t forthcoming.

the company had only £411k in cash at the end of the half year, cue another placing!

well done alex, outstanding work.

Why is the CEO selectively briefing some shareholders and not releasing price sensitive information via RNS to all shareholders?

MCAP is £14.6m @0.3p

Apologies

Said the man wearing orthopaedic shoes😂

It’s a She by the way!